dacarbazine has been researched along with pirarubicin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, H; Matsuyama, S; Nagamachi, Y; Nagashima, K; Okumura, H | 1 |
| Iwafuchi, M; Kaneko, M; Mugishima, H; Nishihira, H; Ohhira, M; Ohnuma, N; Takahashi, H; Takeda, T; Uchino, J; Yokoyama, J | 1 |
| Fukuda, T; Kaneko, T; Morikawa, Y; Nakamichi, T; Suzuki, T | 1 |
| Geng, Y; Li, EX; Li, SM; Shang, JT; Shi, F; Wu, YY; Xu, Z; Zhang, YT | 1 |
1 trial(s) available for dacarbazine and pirarubicin
| Article | Year |
|---|---|
Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Humans; Infant; Japan; Neuroblastoma; Nimustine; Prognosis; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1995 |
3 other study(ies) available for dacarbazine and pirarubicin
| Article | Year |
|---|---|
[Multidisciplinary treatment of advanced neuroblastoma--experience in treatment with the protocol of a group study supported by a grant from Ministry of Health and Welfare].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Enteral Nutrition; Female; Humans; Infant; Male; Mediastinal Neoplasms; Neuroblastoma; Nimustine; Nitrosourea Compounds; Vincristine | 1988 |
Primary cardiac angiosarcoma: 53 months' survival after multidisciplinary therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Heart Neoplasms; Hemangiosarcoma; Humans; Ifosfamide; Survivors; Time Factors | 1997 |
[Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Fibrosarcoma; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Rhabdomyosarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Survival Rate; Thrombocytopenia; Young Adult | 2006 |